• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Aminopiperidines

Recent Advances in the Study of 1-(piperidin-4-yl)piperidin-4-amine (CAS: 1245806-98-7) in Chemical Biology and Pharmaceutical Research

The compound 1-(piperidin-4-yl)piperidin-4-amine (CAS: 1245806-98-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This bicyclic amine scaffold is particularly notable for its role as a key intermediate in the synthesis of various pharmacologically active molecules. Recent studies have highlighted its potential in targeting central nervous system (CNS) disorders, cancer therapeutics, and infectious diseases, making it a compound of considerable interest for further investigation.

One of the most promising areas of research involving 1-(piperidin-4-yl)piperidin-4-amine is its application in the development of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with diseases such as cancer and neurodegenerative disorders. Recent publications have demonstrated that derivatives of this compound exhibit potent inhibitory activity against specific kinases, including those involved in tumor proliferation and metastasis. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the synthesis of novel analogs of 1-(piperidin-4-yl)piperidin-4-amine that showed selective inhibition of cyclin-dependent kinases (CDKs), with promising results in preclinical models of breast cancer.

In addition to its role in oncology, 1-(piperidin-4-yl)piperidin-4-amine has also been explored for its potential in treating CNS disorders. The compound's ability to cross the blood-brain barrier (BBB) makes it an attractive candidate for the development of neuroprotective agents. A recent study in ACS Chemical Neuroscience highlighted its use as a scaffold for designing sigma-1 receptor ligands, which are being investigated for their neuroprotective and anti-inflammatory effects in conditions such as Alzheimer's disease and Parkinson's disease. The study emphasized the compound's structural flexibility, which allows for the introduction of various functional groups to optimize binding affinity and selectivity.

Another significant advancement in the study of 1-(piperidin-4-yl)piperidin-4-amine is its application in antimicrobial research. The rise of antibiotic-resistant pathogens has necessitated the discovery of new antimicrobial agents, and this compound has shown potential in this regard. A 2022 publication in Bioorganic & Medicinal Chemistry Letters described the synthesis of derivatives with broad-spectrum activity against Gram-positive and Gram-negative bacteria. The researchers attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity, a mechanism distinct from traditional antibiotics, thereby reducing the likelihood of resistance development.

Despite these promising findings, challenges remain in the clinical translation of 1-(piperidin-4-yl)piperidin-4-amine-based therapeutics. Issues such as pharmacokinetic properties, toxicity profiles, and scalability of synthesis need to be addressed in future studies. However, the compound's versatility and the growing body of research supporting its pharmacological potential underscore its importance in the field. Continued exploration of its derivatives and mechanisms of action is expected to yield novel therapeutic candidates with improved efficacy and safety profiles.

In conclusion, 1-(piperidin-4-yl)piperidin-4-amine (CAS: 1245806-98-7) represents a valuable scaffold in chemical biology and pharmaceutical research, with applications spanning oncology, CNS disorders, and antimicrobial therapy. Recent studies have provided a solid foundation for further development, and ongoing research is likely to uncover additional therapeutic opportunities. As the field advances, interdisciplinary collaboration will be essential to overcome existing challenges and fully realize the compound's potential in addressing unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)